|
(Unaudited)
(In millions, except per share, stock price and employee data)
2005
| |
2005
|
| |
GAAP |
Differences |
Non-GAAP |
| |
|
|
|
|
TOTAL OPERATING REVENUES |
$6,633 |
|
$6,633 |
| |
Product sales |
5,488 |
|
5,488 |
| |
Royalties |
935 |
|
935 |
| |
Contract revenue |
210 |
|
210 |
 |
| TOTAL
COSTS AND EXPENSES |
$4,712 |
$(181) |
$4,531 |
| |
Cost of sales |
1,011 |
|
1,011 |
| |
Research and development |
1,262 |
|
1,262 |
| |
Marketing, general and administrative |
1,435 |
|
1,435 |
| |
Collaboration profit sharing |
823 |
|
823 |
| |
Recurring charges related to redemption(3) |
123 |
(123) |
- |
| |
Special items |
58 |
(58) |
- |
 |
| Other income, net |
$ 91 |
- |
$ 91 |
 |
| INCOME
(LOSS) DATA |
|
|
|
| |
Income (loss) before taxes and cumulative effect of accounting
change |
$2,013 |
$ 181 |
$2,193 |
| |
Income tax (benefit) provision |
734 |
72 |
806 |
| |
Income (loss) before cumulative effect of accounting change |
1,279 |
108 |
1,387 |
| |
Cumulative effect of accounting change, net of tax |
- |
- |
- |
| |
Net income (loss) |
1,279 |
108 |
1,387 |
 |
| EARNINGS
(LOSS) PER SHARE: |
|
|
|
| |
Basic: |
Earnings
before cumulative effect of accounting change |
$ 1.21 |
$ 0.11 |
$ 1.32 |
| |
|
Cumulative
effect of accounting change, net of tax |
- |
- |
- |
| |
|
Net
earnings per share |
$ 1.21 |
$ 0.11 |
$ 1.32 |
| |
Diluted: |
Earnings
before cumulative effect of accounting change |
$ 1.18 |
$ 0.10 |
$ 1.28 |
| |
|
Cumulative
effect of accounting change, net of tax |
- |
- |
- |
| |
|
Net
earnings per share |
$ 1.18 |
$ 0.10 |
$ 1.28 |
 |
| SELECTED
BALANCE SHEET DATA |
|
|
|
| |
Cash, cash equivalents, short-term investments, and long-term
marketable debt and equity securities |
$3,814 |
|
- |
| |
Accounts receivable |
1,083 |
|
- |
| |
Inventories |
703 |
|
- |
| |
Property, plant and equipment, net |
3,349 |
|
- |
| |
Goodwill |
1,315 |
|
- |
| |
Other intangible assets |
574 |
|
- |
| |
Other long-term assets |
1,041(12) |
|
- |
| |
Total assets |
12,147 |
|
- |
| |
Total current liabilities |
1,660 |
|
- |
| |
Long-term debt |
2,083 (14), (15) |
|
- |
| |
Total liabilities |
4,677 |
|
- |
| |
Total stockholders' equity |
7,470 |
|
- |
 |
| OTHER DATA |
|
|
|
| |
Depreciation
and amortization expense |
$ 370 |
|
- |
| |
Capital
expenditures |
1,400(15) |
|
- |
 |
| SHARE INFORMATION |
|
|
|
| |
Shares
used to compute basic EPS |
1,055 |
|
1,055 |
| |
Shares
used to compute diluted EPS |
1,081 |
|
1,081 |
| |
Actual
year-end |
1,054 |
|
- |
 |
| PER SHARE DATA |
|
|
|
| |
Market
price: |
High |
$ 100.20 |
|
- |
| |
|
Low |
$ 43.90 |
|
- |
| |
Book
value |
$ 7.09 |
|
- |
 |
| NUMBER OF EMPLOYEES AT YEAR-END |
9,563 |
|
|
|
(Table Continued below)
2004-2003
| |
2004
|
2003
|
| |
GAAP |
Differences |
Non-GAAP |
GAAP |
Differences |
Non-GAAP |
| |
|
|
|
|
|
|
|
TOTAL OPERATING REVENUES |
$4,621 |
|
$4,621 |
$3,300 |
|
$3,300 |
| |
Product sales |
3,749 |
|
3,749 |
2,621 |
|
2,621 |
| |
Royalties |
641 |
|
641 |
501 |
|
501 |
| |
Contract revenue |
231 |
|
231 |
178 |
|
178 |
 |
| TOTAL
COSTS AND EXPENSES |
$3,484 |
$(183) |
$3,302 |
$2,496 |
$(41) |
$2,454 |
| |
Cost of sales |
673 |
|
673 |
480 |
|
480 |
| |
Research and development |
948 |
|
948 |
722 |
|
722 |
| |
Marketing, general and administrative |
1,088 |
|
1,088 |
795 |
|
795 |
| |
Collaboration profit sharing |
594 |
|
594 |
458 |
|
458 |
| |
Recurring charges related to redemption(3) |
146 |
(146) |
- |
154 |
(154) |
- |
| |
Special items |
37 |
(37) |
- |
(113) |
113 |
- |
 |
| Other income, net |
$ 83 |
- |
$ 83 |
$ 93 |
- |
$ 93 |
 |
| INCOME
(LOSS) DATA |
|
|
|
|
|
|
| |
Income (loss) before taxes and cumulative effect of accounting
change |
$1,219 |
$ 183 |
$1,402 |
$ 897 |
$ 41 |
$ 939 |
| |
Income tax (benefit) provision |
435 |
73 |
508 |
287 |
16 |
304 |
| |
Income (loss) before cumulative effect of accounting change |
785 |
110 |
894 |
610 |
25 |
635 |
| |
Cumulative effect of accounting change, net of tax |
- |
- |
- |
(48)(1) |
48 |
- |
| |
Net income (loss) |
785 |
110 |
894 |
563 |
72 |
635 |
 |
| EARNINGS
(LOSS) PER SHARE: |
|
|
|
|
|
|
| |
Basic: |
Earnings
before cumulative effect of accounting change |
$ 0.74 |
$ 0.11 |
$ 0.85 |
$ 0.59 |
$ 0.02 |
$ 0.61 |
| |
|
Cumulative
effect of accounting change, net of tax |
- |
- |
- |
(0.05) |
0.05 |
- |
| |
|
Net
earnings per share |
$ 0.74 |
$ 0.11 |
$ 0.85 |
$ 0.54 |
$ 0.07 |
$ 0.61 |
| |
Diluted: |
Earnings
before cumulative effect of accounting change |
$ 0.73 |
$ 0.10 |
$ 0.83 |
$ 0.58 |
$ 0.02 |
$ 0.60 |
| |
|
Cumulative
effect of accounting change, net of tax |
|
- |
- |
(0.05) |
0.05 |
- |
| |
|
Net
earnings per share |
$ 0.73 |
$ 0.10 |
$ 0.83 |
$ 0.53 |
$ 0.07 |
$ 0.60 |
 |
| SELECTED
BALANCE SHEET DATA |
|
|
|
|
|
|
| |
Cash, cash equivalents, short-term investments, and long-term
marketable debt and equity securities |
$2,780 |
|
- |
$2,935 |
|
- |
| |
Accounts receivable |
960 |
|
- |
599 |
|
- |
| |
Inventories |
590 |
|
- |
470 |
|
- |
| |
Property, plant and equipment, net |
2,091(1) |
|
- |
1,618(1) |
|
- |
| |
Goodwill |
1,315 |
|
- |
1,315 |
|
- |
| |
Other intangible assets |
668 |
|
- |
811 |
|
- |
| |
Other long-term assets |
788(12) |
|
- |
811(12) |
|
- |
| |
Total assets |
9,403 |
|
- |
8,759 |
|
- |
| |
Total current liabilities |
1,238 |
|
- |
893 |
|
- |
| |
Long-term debt |
412(1) |
|
- |
412(1) |
|
- |
| |
Total liabilities |
2,621 |
|
- |
2,239 |
|
- |
| |
Total stockholders' equity |
6,782 |
|
- |
6,520 |
|
- |
 |
| OTHER DATA |
|
|
|
|
|
|
| |
Depreciation
and amortization expense |
$ 353 |
|
- |
$ 295 |
|
- |
| |
Capital
expenditures |
650 |
|
- |
322 |
|
- |
 |
| SHARE INFORMATION |
|
|
|
|
|
|
| |
Shares
used to compute basic EPS |
1,055 |
|
1,055 |
1,035 |
|
1,035 |
| |
Shares
used to compute diluted EPS |
1,079 |
|
1,079 |
1,058 |
|
1,058 |
| |
Actual
year-end |
1,047 |
|
- |
1,049 |
|
- |
 |
| PER SHARE DATA |
|
|
|
|
|
|
| |
Market
price: |
High |
$ 68.25 |
|
- |
$ 47.68 |
|
- |
| |
|
Low |
$ 41.00 |
|
- |
$ 15.77 |
|
- |
| |
Book
value |
$ 6.48 |
|
- |
$ 6.21 |
|
- |
 |
| NUMBER OF EMPLOYEES AT YEAR-END |
7,646 |
|
|
6,226 |
|
|
|
(Table Continued below)
2002-2001
| |
2002
|
2001
|
| |
GAAP |
Differences |
Non-GAAP |
GAAP |
Differences |
Non-GAAP |
|
TOTAL OPERATING REVENUES |
$2,584 |
|
$2,584 |
$2,044 |
|
$2,044 |
| |
Product sales |
2,164 |
|
2,164 |
1,743 |
|
1,743 |
| |
Royalties |
366 |
|
366 |
265 |
|
265 |
| |
Contract revenue |
55 |
|
55 |
37 |
|
37 |
 |
| TOTAL
COSTS AND EXPENSES |
$2,662 |
$(700) |
$1,962 |
$1,896 |
$(322) |
$1,574 |
| |
Cost of sales |
442 |
|
442 |
355 |
|
355 |
| |
Research and development |
624 |
|
624 |
526 |
|
526 |
| |
Marketing, general and administrative |
546 |
|
546 |
447 |
|
447 |
| |
Collaboration profit sharing |
351 |
|
351 |
247 |
|
247 |
| |
Recurring charges related to redemption(3) |
156(11) |
(156) |
- |
322 |
(322) |
- |
| |
Special items |
544(10) |
(544) |
- |
- |
- |
- |
 |
| Other income, net |
$ 108 |
- |
$ 108 |
$135(8) |
$ (10) |
$ 125 |
 |
| INCOME
(LOSS) DATA |
|
|
|
|
|
|
| |
Income (loss) before taxes and cumulative effect of accounting
change |
$ 30 |
$ 700 |
$ 729 |
$ 283 |
$ 312 |
$ 595 |
| |
Income tax (benefit) provision |
(34) |
280 |
246 |
127 |
63 |
190 |
| |
Income (loss) before cumulative effect of accounting change |
64 |
420 |
484 |
156 |
249 |
405 |
| |
Cumulative effect of accounting change, net of tax |
- |
- |
- |
(6)(8) |
6 |
- |
| |
Net income (loss) |
64(11) |
420 |
484 |
150 |
254 |
405 |
 |
| EARNINGS
(LOSS) PER SHARE: |
|
|
|
|
|
|
| |
Basic: |
Earnings
before cumulative effect of accounting change |
$ 0.06 |
$ 0.41 |
$ 0.47 |
$ 0.15 |
$ 0.23 |
$ 0.38 |
| |
|
Cumulative
effect of accounting change, net of tax |
- |
- |
- |
(0.01) |
0.01 |
- |
| |
|
Net
earnings per share |
$ 0.06 |
$ 0.41 |
$ 0.47 |
$ 0.14 |
$ 0.24 |
$ 0.38 |
| |
Diluted: |
Earnings
before cumulative effect of accounting change |
$ 0.06 |
$ 0.40 |
$ 0.46 |
$ 0.15 |
$ 0.23 |
$ 0.38 |
| |
|
Cumulative
effect of accounting change, net of tax |
- |
- |
- |
(0.01) |
0.01 |
- |
| |
|
Net
earnings per share |
$ 0.06 |
$ 0.40 |
$ 0.46 |
$ 0.14 |
$ 0.24 |
$ 0.38 |
 |
| SELECTED
BALANCE SHEET DATA |
|
|
|
|
|
|
| |
Cash, cash equivalents, short-term investments, and long-term
marketable debt and equity securities |
$1,602 |
|
- |
$2,865 |
|
- |
| |
Accounts receivable |
443 |
|
- |
330 |
|
- |
| |
Inventories |
394 |
|
- |
357 |
|
- |
| |
Property, plant and equipment, net |
1,069 |
|
- |
866 |
|
- |
| |
Goodwill |
1,315 |
|
- |
1,303 |
|
- |
| |
Other intangible assets |
928 |
|
- |
1,113 |
|
- |
| |
Other long-term assets |
790(12) |
|
- |
127 |
|
- |
| |
Total assets |
6,776 |
|
- |
7,162 |
|
- |
| |
Total current liabilities |
661 |
|
- |
677(9) |
|
- |
| |
Long-term debt |
- |
|
- |
- |
|
- |
| |
Total liabilities |
1,437 |
|
- |
1,242 |
|
- |
| |
Total stockholders' equity |
5,339 |
|
- |
5,920 |
|
- |
 |
| OTHER DATA |
|
|
|
|
|
|
| |
Depreciation
and amortization expense |
$275(11) |
|
- |
$ 428 |
|
- |
| |
Capital
expenditures |
323 |
|
- |
213 |
|
- |
 |
| SHARE INFORMATION |
|
|
|
|
|
|
| |
Shares
used to compute basic EPS |
1,038 |
|
1,038 |
1,054 |
|
1,054 |
| |
Shares
used to compute diluted EPS |
1,049 |
|
1,049 |
1,071 |
|
1,071 |
| |
Actual
year-end |
1,026 |
|
- |
1,057 |
|
- |
 |
| PER SHARE DATA |
|
|
|
|
|
|
| |
Market
price: |
High |
$ 27.58 |
|
- |
$ 42.00 |
|
- |
| |
|
Low |
$ 12.55 |
|
- |
$ 19.00 |
|
- |
| |
Book
value |
$ 5.21 |
|
- |
$ 5.60 |
|
- |
 |
| NUMBER OF EMPLOYEES AT YEAR-END |
5,252 |
|
|
4,950 |
|
|
|
(Table Continued below)
2000-1999
| |
2000
|
1999
|
| |
GAAP |
Differences |
Non-GAAP |
GAAP(6) |
Differences |
Non-GAAP |
|
TOTAL OPERATING REVENUES |
$1,514 |
|
$1,514 |
$1,292 |
|
$1,292 |
| |
Product sales |
1,278 |
|
1,278 |
1,039 |
|
1,039 |
| |
Royalties |
207 |
|
207 |
189 |
|
189 |
| |
Contract revenue |
29(5) |
|
29 |
64 |
|
64 |
 |
| TOTAL
COSTS AND EXPENSES |
$1,726 |
$(468) |
$1,258 |
$2,730 |
$(1,729) |
$1,001 |
| |
Cost of sales |
365(7) |
(93) |
272 |
286(7) |
(93) |
192 |
| |
Research and development |
490 |
|
490 |
367 |
|
367 |
| |
Marketing, general and administrative |
367 |
|
367 |
367 |
|
367 |
| |
Collaboration profit sharing |
129 |
|
129 |
74 |
|
74 |
| |
Recurring charges related to redemption(3) |
375 |
(375) |
- |
198 |
(198) |
- |
| |
Special items |
- |
- |
- |
1,438(2) |
(1,438) |
- |
 |
| Other income, net |
$ 216 |
- |
$ 216 |
$ 77 |
- |
$ 77 |
 |
| INCOME
(LOSS) DATA |
|
|
|
|
|
|
| |
Income (loss) before taxes and cumulative effect of accounting
change |
$ 4 |
$ 468 |
$ 472 |
$(1,361) |
$1,729 |
$ 368 |
| |
Income tax (benefit) provision |
20 |
127 |
147 |
(203) |
325 |
122 |
| |
Income (loss) before cumulative effect of accounting change |
(16) |
342 |
325 |
(1,158) |
1,404 |
247 |
| |
Cumulative effect of accounting change, net of tax |
(58)(5) |
58 |
- |
- |
- |
- |
| |
Net income (loss) |
(74) |
399 |
325 |
(1,158) |
1,404 |
247 |
 |
| EARNINGS
(LOSS) PER SHARE: |
|
|
|
|
|
|
| |
Basic: |
Earnings
before cumulative effect of accounting change |
$ (0.02) |
$ 0.33 |
$ 0.31 |
$ (1.13) |
$ 1.37 |
$ 0.24 |
| |
|
Cumulative
effect of accounting change, net of tax |
(0.05) |
0.05 |
- |
- |
- |
- |
| |
|
Net
earnings per share |
$ (0.07) |
$ 0.38 |
$ 0.31 |
$ (1.13) |
$ 1.37 |
$ 0.24 |
| |
Diluted: |
Earnings
before cumulative effect of accounting change |
$ (0.02) |
$ 0.32 |
$ 0.30 |
$ (1.13) |
$ 1.36 |
$ 0.23 |
| |
|
Cumulative
effect of accounting change, net of tax |
(0.05) |
0.05 |
- |
- |
- |
- |
| |
|
Net
earnings per share |
$ (0.07) |
$ 0.37 |
$ 0.30 |
$ (1.13) |
$ 1.36 |
$ 0.23 |
 |
| SELECTED
BALANCE SHEET DATA |
|
|
|
|
|
|
| |
Cash, cash equivalents, short-term investments, and long-term
marketable debt and equity securities |
$2,459 |
|
- |
$1,957 |
|
- |
| |
Accounts receivable |
284 |
|
- |
238 |
|
- |
| |
Inventories |
266 |
|
- |
275 |
|
- |
| |
Property, plant and equipment, net |
753 |
|
- |
730 |
|
- |
| |
Goodwill |
1,456 |
|
- |
1,609 |
|
- |
| |
Other intangible assets |
1,280 |
|
- |
1,453 |
|
- |
| |
Other long-term assets |
169 |
|
- |
201 |
|
- |
| |
Total assets |
6,739 |
|
- |
6,561 |
|
- |
| |
Total current liabilities |
475 |
|
- |
503 |
|
- |
| |
Long-term debt |
150 |
|
- |
150 |
|
- |
| |
Total liabilities |
1,065 |
|
- |
1,291 |
|
- |
| |
Total stockholders' equity |
5,674 |
|
- |
5,270(4) |
|
- |
 |
| OTHER DATA |
|
|
|
|
|
|
| |
Depreciation
and amortization expense |
$ 463 |
|
- |
$ 281 |
|
- |
| |
Capital
expenditures |
113 |
|
- |
95 |
|
- |
 |
| SHARE INFORMATION |
|
|
|
|
|
|
| |
Shares
used to compute basic EPS |
1,044 |
|
1,044 |
1,026 |
|
1,026 |
| |
Shares
used to compute diluted EPS |
1,044 |
28 |
1,072 |
1,026 |
33 |
1,059 |
| |
Actual
year-end |
1,051 |
|
- |
1,032 |
|
- |
 |
| PER SHARE DATA |
|
|
|
|
|
|
| |
Market
price: |
High |
$ 61.25 |
|
- |
$ 11.25
$35.75** |
|
- |
| |
|
Low |
$ 21.13 |
|
- |
$ 9.32
$12.13** |
|
- |
| |
Book
value |
$ 5.40 |
|
- |
$ 5.10 |
|
|
 |
| NUMBER OF EMPLOYEES AT YEAR-END |
4,459 |
|
|
3,883 |
|
|
|
(Table Continued below)
1998-1995
| |
1998
|
1997
|
1996
|
1995
|
|
TOTAL OPERATING REVENUES |
$1,053 |
$ 936 |
$ 904 |
$ 851 |
| |
Product sales |
718 |
585 |
583 |
635 |
| |
Royalties |
230 |
241 |
215 |
191 |
| |
Contract revenue |
106 |
110 |
107 |
25 |
 |
| TOTAL
COSTS AND EXPENSES |
$ 874 |
$ 839 |
$ 816 |
$ 731 |
| |
Cost of sales |
139 |
103 |
105 |
98 |
| |
Research and development |
396 |
471 |
471 |
363 |
| |
Marketing, general and administrative |
299 |
266 |
240 |
245 |
| |
Collaboration profit sharing |
40 |
- |
- |
- |
| |
Recurring charges related to redemption(3) |
- |
- |
- |
- |
| |
Special items |
- |
- |
- |
25(13) |
 |
| Other income, net |
$ 73 |
$ 73 |
$ 59 |
$ 52 |
 |
| INCOME
(LOSS) DATA |
|
|
|
|
| |
Income (loss) before taxes and cumulative effect of accounting
change |
$ 253 |
$ 170 |
$ 148 |
$ 172 |
| |
Income tax (benefit) provision |
71 |
41 |
30 |
26 |
| |
Income (loss) before cumulative effect of accounting change |
182 |
129 |
118 |
146 |
| |
Cumulative effect of accounting change, net of tax |
- |
- |
- |
- |
| |
Net income (loss) |
182 |
129 |
118 |
146 |
 |
| EARNINGS
(LOSS) PER SHARE: |
|
|
|
|
| |
Basic: |
Earnings
before cumulative effect of accounting change |
$ 0.18 |
$ 0.13 |
$ 0.12 |
$ 0.15 |
| |
|
Cumulative
effect of accounting change, net of tax |
- |
- |
- |
- |
| |
|
Net
earnings per share |
$ 0.18 |
$ 0.13 |
$ 0.12 |
$ 0.15 |
| |
Diluted: |
Earnings
before cumulative effect of accounting change |
$ 0.18 |
$ 0.13 |
$ 0.12 |
$ 0.15 |
| |
|
Cumulative
effect of accounting change, net of tax |
- |
- |
- |
- |
| |
|
Net
earnings per share |
$ 0.18 |
$ 0.13 |
$ 0.12 |
$ 0.15 |
 |
| SELECTED
BALANCE SHEET DATA |
|
|
|
|
| |
Cash, cash equivalents, short-term investments, and long-term
marketable debt and equity securities |
$1,605 |
$1,287 |
$1,159 |
$1,097 |
| |
Accounts receivable |
162 |
189 |
198 |
172 |
| |
Inventories |
149 |
116 |
92 |
94 |
| |
Property, plant and equipment, net |
700 |
683 |
586 |
504 |
| |
Goodwill |
- |
- |
- |
- |
| |
Other intangible assets |
65 |
55 |
40 |
42 |
| |
Other long-term assets |
131 |
123 |
109 |
63 |
| |
Total assets |
2,868 |
2,507 |
2,226 |
2,011 |
| |
Total current liabilities |
303 |
289 |
250 |
233 |
| |
Long-term debt |
150 |
150 |
150 |
150 |
| |
Total liabilities |
524 |
476 |
425 |
409 |
| |
Total stockholders' equity |
2,344 |
2,031 |
1,801 |
1,602 |
 |
| OTHER DATA |
|
|
|
|
| |
Depreciation
and amortization expense |
$ 78 |
$ 66 |
$ 62 |
$ 58 |
| |
Capital
expenditures |
88 |
155 |
142 |
70 |
 |
| SHARE INFORMATION |
|
|
|
|
| |
Shares
used to compute basic EPS |
1,007 |
984 |
965 |
946 |
| |
Shares
used to compute diluted EPS |
1,039 |
1,011 |
992 |
974 |
| |
Actual
year-end |
1,017 |
994 |
971 |
954 |
 |
| PER SHARE DATA |
|
|
|
|
| |
Market
price: |
High |
$ 9.97 |
$ 7.58 |
$ 6.92 |
$ 6.63* |
| |
|
Low |
$ 7.41 |
$ 6.66 |
$ 6.42 |
$ 5.56* |
| |
Book
value |
$ 2.30 |
$ 2.04 |
$ 1.85 |
$ 1.68 |
 |
| NUMBER OF EMPLOYEES AT YEAR-END |
3,389 |
3,242 |
3,071 |
2,842 |
|
The preceding 11-year Financial Summary reflects adoption of Financial Accounting Standards Board Interpretation No. 46 (FIN 46), as revised by FIN 46R, in 2003, Statement of Financial Accounting Standards (FAS) No. 141, 142, 144 and 148 in 2002, FAS 133 in 2001, the Securities and Exchange Commission's Staff Accounting Bulletin No. 101 (SAB 101) in 2000, FAS 130 and 131 in 1998, FAS 128 and 129 in 1997, FAS 121 in 1996, FAS 115 in 1994.
We have paid no dividends. We currently intend to retain all future income for use in the operation of our business and for future stock repurchases and, therefore, do not anticipate paying any cash dividends in the foreseeable future.
All share and per share amounts reflect two-for-one stock splits of our Common Stock that were effected in 2004, 2000 and 1999.
| * |
Special Common Stock began trading October 26, 1995. On October
25, 1995, pursuant to the 1995 Agreement with Roche Holdings, Inc.
(Roche), each share of our Common Stock not held by Roche or its affiliates
automatically converted to one share of Special Common Stock.
|
| ** |
Common Stock began trading July 20, 1999; prior to that date, shares
were Special Common Stock. On June 30, 1999, we redeemed all of
our outstanding Special Common Stock held by stockholders other
than Roche (also known as the Redemption). Roche's percentage
ownership of our outstanding equity increased from 65 percent to 100
percent. On July 23, 1999, October 26, 1999, and March 29, 2000,
Roche completed public offerings of our Common Stock. Roche also
publicly offered zero-coupon notes in January 2000 which were exchangeable
for our common stock held by Roche. Roche called these
notes in March 2004. Through April 5, 2004, the expiration date for
investors to tender these notes, approximately 26 million shares were
issued in exchange for the notes, thereby reducing Roche's ownership
of Genentech common stock to 587,189,380 shares. At December 31,
2005, Roche's ownership percentage was 55.7 percent. |
Non-GAAP amounts exclude: (i) recurring charges related to the Redemption; (ii) litigation-related special items in 2005 was comprised of accrued
interest and bond costs related to the City of Hope (COH) judgment and net
amounts paid related to other litigation settlements, in 2004 it was comprised
of accrued interest and bond costs related to the COH judgment (net of a
released accrual on a separate litigation matter), in 2003 it was comprised
of Amgen and Bayer litigation settlements (net of accrued interest and bond
costs related to the COH litigation), and in 2002 it was comprised of special
charges for the COH judgment in the second quarter of 2002, including
accrued interest and bond costs, and certain other litigation-related matters,
(iii) special charges in 1999 related to the Redemption and the effects of
"push-down" accounting as required by U.S. generally accepted accounting
principles, and legal settlements, (iv) costs in 2000 and 1999 related to the
sale of inventory that was written up at the Redemption, (v) the cumulative
effect of accounting changes, (vi) the changes in fair value of certain derivatives
recorded in "other income, net" in 2001, and (vii) all related tax effects.
For further information on these items, see the "Results of Operations" section
of Item 7, "Management's Discussion and Analysis of Financial Condition
and Results of Operations," of Part II of our Form 10-K for the respective
years on file with the Securities and Exchange Commission (SEC).
(1) Reflects the impact of the adoption of FIN 46, "Consolidation of Variable Interest Entities."
(2) Charges related to Redemption and push-down accounting ($1,208
million) and legal settlements ($230 million).
(3) Primarily reflects amortization of other intangible assets in 2005,
2004, 2003, 2002, 2001, 2000, and 1999, and goodwill amortization
in 2001, 2000 and 1999 related to the Redemption and push-down
accounting.
(4) Reflects the effect of the Redemption and related push-down accounting
of $5,202 million of excess purchase price over net book value,
net of charges and accumulated amortization of goodwill and other
intangible assets.
(5) Reflects the impact of the adoption of SAB 101 on revenue recognition
effective January 1, 2000.
(6) GAAP 1999 results reflect the June 30, 1999 redemption and pushdown
accounting and include the combined New Basis and Old Basis
periods presented in the 1999 Consolidated Statements of Operations
and Consolidated Statements of Cash Flows. Refer to our 2001 Form
10-K (Part II, Item 8) on file with the SEC.
(7) Includes costs related to the sale of inventory that was written up at
the Redemption due to push-down accounting.
(8) Reflects the effect of the adoption of FAS 133 on Accounting for
Derivative Instruments and Hedging Activities.
(9) The $150 million long-term debt was reclassified to current liabilities to reflect the March 27, 2002 maturity.
(10) Amount includes litigation-related special charges comprised of the
COH judgment in the second quarter of 2002, including accrued
interest and costs related to obtaining a surety bond, and certain other
litigation-related matters. For further information on these charges, see
the "Results of Operations" section of Item 7, "Management's Discussion
and Analysis of Financial Condition and Results of Operations," of
Part II of our 2002 Form 10-K on file with the SEC.
(11) We adopted FAS 141 on Business Combinations and FAS 142 on
Goodwill and other Intangible Assets on January 1, 2002. In accordance
with FAS 141 and 142, we discontinued the amortization of
goodwill and our trained and assembled workforce intangible asset,
which resulted in an increase in reported net income by approximately
$158 million (or $0.15 per share) in 2002, as compared to the accounting
prior to the adoption of FAS 141 and 142.
(12) Includes approximately $735 million at December 31, 2005, $682
million at December 31, 2004 and $630 million at December 31, 2003
and 2002 of restricted cash pledged to secure a bond for the COH
judgment. For further information on the COH judgment, see Note 7,
"Leases, Commitments and Contingencies" in Part II, Item 8 of our
2005 Form 10-K on file with the SEC.
(13) Primarily includes charges related to 1995 merger and the 1995
Agreement with Roche ($21 million).
(14) Includes approximately $2 billion related to our debt issuance in
July 2005, net of the repayment of $425 million in the third quarter
of 2005 to extinguish the debt and noncontrolling interest related
to a synthetic lease obligation. For further information, see Note 7,
"Leases, Commitments and Contingencies" in Part II, Item 8 of our
2005 10-K on file with the SEC.
(15) In 2005, we capitalized costs of approximately $94 million related to
our accounting for a construction project of which we are considered
to be the owner during the construction period. These costs have been
excluded from 2005 capital expenditures, and have been recognized
as a construction financing obligation in long-term debt.
|